Related Experiment Video
Updated: May 8, 2026
11:44
Monochrome Multiplex Quantitative PCR Telomere Length Measurement
Published on: March 22, 2024
Telomere length and Parkinson's disease in men: a nested case-control study
M Schürks1, J Buring, R Dushkes
1Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Neurology, University Hospital Essen, Essen, Germany.
European Journal of Neurology
|September 10, 2013
Summary
Shorter telomere length was unexpectedly linked to a lower risk of Parkinson's disease (PD) in a large study of men. Further research is needed to understand this counterintuitive finding regarding telomere length and PD.
Area of Science:
- Neuroscience
- Genetics
- Epidemiology
Background:
- Telomere shortening is linked to neurodegenerative disorders.
- Existing data on telomere length and Parkinson's disease (PD) risk are inconclusive.
Purpose of the Study:
- To investigate the association between relative telomere length (RTL) and the risk of developing Parkinson's disease (PD).
Main Methods:
- Nested case-control study within the Physicians' Health Study (2010).
- Quantitative PCR used to measure relative telomere length (RTL) from DNA in peripheral blood leukocytes.
- Conditional logistic regression analysis to assess PD risk associated with RTL.
Main Results:
- Shorter median telomere length observed in controls compared to Parkinson's disease (PD) cases (P = 0.02).
- Individuals in the lowest quartile of RTL had a reduced risk of PD (OR = 0.66; Ptrend = 0.02).
- This association remained consistent after adjusting for multiple covariates.
Conclusions:
- Contrary to expectations, shorter telomeres were associated with a reduced risk of Parkinson's disease (PD) in this cohort.
- The counterintuitive nature of this finding warrants further investigation into the relationship between telomere length and PD.
Related Concept Videos
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
02:41Telomeres and Telomerase
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.